申请人:SMITHKLINE BECKMAN CORPORATION
公开号:EP0225718A2
公开(公告)日:1987-06-16
Compounds of formula
in which:
n is 0-5;
R is hydrogen or C1-4 alkyl; and
X is hydrogen, halo, C1-4 alkyl, CN, N02 S02NH2, COOH, CHO, OH, CH20H, C1-4 alkoxy, CF3, S02CH3, S02CF3, or CO2CaH2a+1 where a is 1-5, or any accessible combination thereof of up to 5 substituents; processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them and their use in therapy as dopamine-β-hydroxylase inhibitors.
式中的化合物,其中:n 为 0-5;R 为氢或 C1-4 烷基;X 为氢、卤代、C1-4 烷基、CN、N02 S02NH2、COOH、CHO、OH、CH20H、C1-4 烷氧基、CF3、S02CH3、S02CF3 或 CO2CaH2a+1 其中 a 为 1-5,或其中最多 5 个取代基的任何可获得的组合;其制备工艺、制备过程中有用的中间体、含有它们的药物组合物以及它们作为多巴胺-β-羟化酶抑制剂在治疗中的用途。